Emmes is a leading contract research organization that partners with public, private foundation, and commercial biopharmaceutical clients to develop new treatment options for diseases and disorders impacting public health. The Company provides a full suite of clinical research services as well as a number of supporting specialty, analytical, and technology services. In particular, Emmes is the pre-eminent provider of biostatistics-related services such as protocol development, study design, study monitoring, data analysis, data management, and data reporting with expertise across a wide range of therapeutic areas. Emmes has more than 600 highly skilled and experienced employees across the U.S., Canada, and India, and serves clients globally. The Emmes Corporation was founded in 1977 and is headquartered in Rockville, Maryland.

Based in New York City and San Francisco, Behrman Capital was founded in 1991 by Grant G. and Darryl G. Behrman. The firm invests in management buyouts, leveraged buildups and recapitalizations of established growth businesses. The company’s investments are focused in three industries: aerospace and defense, healthcare services, and specialty manufacturing and distribution. The firm has raised in excess of $3.0 billion since inception and is currently investing out of its sixth fund.

Delancey Street Partners is an independent, industry-focused investment bank. We serve CEOs, Entrepreneurs, Shareholders and Boards of Directors of high growth and middle market private and public companies. Our services include strategic advisory, capital raising and independent board advice. We advise on sell-side and buy-side M&A, growth capital financings and recapitalizations. Our focus sectors include Healthcare, Business & Technology Services, Industrial & Industrial Technology, and Infrastructure. We form long-term partnerships with our clients and commit to managing each engagement with senior professionals who bring years of experience and insight.